Suppr超能文献

模拟胃肠道流动条件下难溶性药物溶出的控制。2. 药物与缓冲剂的共压制。

Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 2. Cocompression of drugs with buffers.

作者信息

Chakrabarti S, Southard M Z

机构信息

Chemical & Petroleum Engineering Department, University of Kansas, Lawrence 66045, USA.

出版信息

J Pharm Sci. 1997 Apr;86(4):465-9. doi: 10.1021/js960334f.

Abstract

The objective of this study was to determine the primary formulation properties that affect the dissolution rate of poorly soluble nondisintegrating drugs. This work focused on compression of orally administered acidic drugs with ionizable buffers. Naproxen was used as the poorly soluble model drug, and calcium salts of carbonic, citric, and phosphoric acids were used as formulation buffers. Gastrointestinal tract (GI) dissolution was simulated in a laminar flow apparatus by exposing a drug/buffer tablet to aqueous solution of a given pH at a constant flow rate. Although formulation with a buffer resulted in reduced available drug surface area, the absolute drug dissolution rate and flux increased with increased buffer content to a maximum from tablets having equal weights of drug and buffer. This buffer-induced enhancement was seen not only in GI tract simulation (pH 7), but also at pH 2 (stomach conditions), where acidic drugs remain in their poorly soluble form upon dissolution. The flux increase was much greater than that achieved by using the same amount of an inert excipient in the solid formulation. Dissolution rates were also increased by decreased drug and buffer particle sizes and increased fluid flow rate. Drug dissolution rates were inversely proportional to intrinsic buffer solubilities: The model drug actually dissolved fastest when the buffer solubility was lower than that of the drug. Dissolution rates were apparently insensitive to the relative proximity of the drug and buffer ionization constants.

摘要

本研究的目的是确定影响难溶性非崩解药物溶出速率的主要制剂特性。这项工作聚焦于用可离子化缓冲剂对口服酸性药物进行压片。萘普生被用作难溶性模型药物,碳酸、柠檬酸和磷酸的钙盐被用作制剂缓冲剂。在层流装置中,通过将药物/缓冲剂片剂以恒定流速暴露于给定pH值的水溶液中来模拟胃肠道(GI)溶出。尽管使用缓冲剂的制剂会导致可用药物表面积减小,但绝对药物溶出速率和通量会随着缓冲剂含量的增加而增加,对于药物和缓冲剂重量相等的片剂,会增加到最大值。这种缓冲剂诱导的增强不仅在胃肠道模拟(pH 7)中可见,在pH 2(胃部条件)下也可见,在该条件下酸性药物在溶出时仍以其难溶形式存在。通量的增加远大于在固体制剂中使用相同量的惰性辅料所实现的增加。药物和缓冲剂粒径的减小以及流体流速的增加也会提高溶出速率。药物溶出速率与缓冲剂的固有溶解度成反比:当缓冲剂溶解度低于药物溶解度时,模型药物实际上溶出最快。溶出速率显然对药物和缓冲剂电离常数的相对接近程度不敏感。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验